Alteration of avoidance and ingestive behavior after destruction of central catecholamine pathways with 6-hydroxydopamine.
D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001835:Body Weight; D001921:Brain / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D002421:Caudate Nucleus / Q000187:drug effects / Q000502:physiology; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology; D003342:Corpus Striatum / Q000187:drug effects / Q000502:physiology; D005247:Feeding Behavior / Q000187:drug effects*; D005917:Globus Pallidus / Q000187:drug effects / Q000502:physiology; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology; D006892:Hydroxydopamines / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects / Q000502:physiology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008845:Microinjections; D009638:Norepinephrine / Q000494:pharmacology; D009928:Organ Specificity; D051381:Rats; D013238:Stereotaxic Techniques; D013997:Time Factors
D006892:Hydroxydopamines; D008781:Methyltyrosines; D009638:Norepinephrine